welzo Establishes New Subsidiary in Singapore to Accelerate Expansion into Southeast Asia
FUKUOKA, Japan, June 3, 2025 /PRNewswire/ -- welzo Inc., an innovation-driven company in the agri-horticultural sector (Head Office: Hakata-ku, Fukuoka City, Fukuoka Prefecture; President and CEO: Yoshifumi Kanao), has established a wholly owned...
LITEON and ASOCS Announce Integration of LITEON Radio Unit with ASOCS RAN Software to Deliver High-Performance Private 5G Solutions for Industry 4.0
TAIPEI, June 2, 2025 /PRNewswire/ -- LITEON Technology Corporation (https://www.liteon.com/en), a global leader in power management and optoelectronic technologies, proudly announces its strategic collaboration with ASOCS (www.asocscloud.com), a...
Deloitte Launches its Asia Pacific Agentic AI Centre of Excellence to Accelerate Scalable, Trusted AI Transformation
Deloitte launches its Asia Pacific Agentic AI Centre of Excellence, bringing together over 120 AI specialists in the region to help organisations achieve scalable, responsible AI transformation Agentic AI empowers businesses to automate complex...
VINEXPO ASIA 2025 OFFERS CLARITY FOR ASEAN TRADE IN SHIFTING LANDSCAPE
SINGAPORE, June 3, 2025 /PRNewswire/ -- In a shifting global landscape, clarity matters. From 27 to 29 May, Vinexpo Asia 2025 gathered 8,998 trade participants at Marina Bay Sands, reinforcing its position as both a business catalyst and a strategic...
2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer
YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a Phase 2 clinical study conducted in China evaluating...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025
BEIJING, June 3, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising...